About Us

Photo courtesy of Cincinnati Children's Hospital Medical CenterThe Children’s Oncology Group (COG) is the most experienced organization in the world in clinical development of new therapeutics for children and adolescents with cancer.

The Children’s Oncology Group Phase 1 & Pilot Consortium is a limited institution consortium, comprised of 21 premier pediatric oncology programs in the country that were selected through a peer review process. Formed in 2002, the primary goals of the consortium are to identify and develop effective new agents for children and adolescents with cancer through rational and efficient clinical and laboratory research. The consortium serves as a national and international model for new drug development in pediatric oncology.

The consortium successfully leverages the database infrastructure and resources of the parent Children’s Oncology Group (COG) while maintaining its own administrative and operational infrastructure to ensure rapid development, implementation and reporting of specialized and complex early phase clinical trials. The consortium has expert resources for the conduct of translational biology, pharmacokinetic, and pharmacogenetics studies, and has developed a state-of-the art infrastructure to facilitate image transfer of specialized correlative imaging studies for central review and analyses.

DVL Chair
Dr. Brenda J. Weigel, MD
University of Minnesota Medical Center-Fairview
Department of Pediatrics, Hem/Onc/BMT
420 Delaware Street, SE
MMC 366
Minneapolis, MN 55455
Tel: 612 626-5501
Fax: 612 624-3913
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

DVL Vice-Chair
Dr. Elizabeth Fox, MD
Children’s Hospital of Philadelphia
Division of Oncology
3501 Civic Center Blvd, CTRB-4016
Philadelphia, PA 19104
Tel: 267 425-3010
Fax: 267 425-0113
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Operations Director, Phase I & Pilot Consortium
Ms. Thalia Beeles, MPH
Children's Oncology Group
222 E. Huntington Drive, Suite 100
Monrovia, CA 91016
Tel: (626) 241-1630
Fax: (626) 445-4334
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Vice Chair of Regulatory Affairs
Dr. Stacey L. Berg, MD
Baylor College of Medicine
Pediatric Oncology
6621 Fannin Street, MC3-3320
Houston TX 77030
Tel: 832 824-4588
Fax: 832 825-4039
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Vice Chair of Pharmacology
Dr. Joel Reid, PhD
Mayo Clinic
19-365 Gonda Building
200 First Street Southwest
Rochester, MN 55905
Tel: 507 284-0822
Fax: 507 284-3906
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Vice Chair for Biology- Solid Tumors
Stephen X. Skapek, MD
UT Southwestern/Simmons Cancer Center-Dallas
Pediatrics
5323 Harry Hines Blvd
Dallas, TX 75390-9063
Tel: 214 648-3081
Fax: 214 648-3122
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Vice Chair for Biology- Hematologic Malignancies
Sarah K. Tasian, MD
Children's Hospital of Philadelphia
Division of Oncology
3501 Civic Center Blvd
CTRB, 3rd Floor Room 3100
Philadelphia, PA 19104
Tel: 267 425-0118
Fax: 215 590-3770
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Vice Chair of Radiology
Dr. Stephan Voss, MD PhD
Dana-Farber Cancer Institute
Children’s Hospital Boston
300 Longwood Avenue
Boston, MA 02115
Tel: 617 355-8377
Fax: 617 730-0573
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

COG Operations Center
222 E. Huntington Drive, Suite 100
Monrovia, CA 91016
Tel: (626) 447-0064
Fax: (626) 445-4334

NCTN_h_COLOR_Badge_180x60.png

 

 

 

   amazon smile donate